BancorpSouth’s Novartis NVS Stock Holding History

BancorpSouth’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-2,783	Closed	-$206K	–	256
2016 Q2	$206K	Buy	+2,783	New	+$192K	0.02%	220
2016 Q1	–	Sell	-2,861	Closed	-$221K	–	266
2015 Q4	$221K	Hold	2,861	–	–	0.03%	212
2015 Q3	$236K	Sell	2,861 -326	-10%	-$29K	0.03%	185
2015 Q2	$281K	Sell	3,187 -34	-1%	-$3.12K	0.03%	171
2015 Q1	$285K	Sell	3,221 -2,201	-41%	-$195K	0.03%	170
2014 Q4	$450K	Sell	5,422 -30	-0.6%	-$2.49K	0.05%	141
2014 Q3	$460K	Hold	5,452	–	–	0.05%	144
2014 Q2	$442K	Sell	5,452 -176	-3%	-$13.8K	0.05%	152
2014 Q1	$429K	Buy	+5,628	New	+$410K	0.05%	167

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

BancorpSouth's NVS Position: Q3 2016 in Review

BancorpSouth sold out of Novartis (NVS) in Q3 2016, closing a stake of 2,783 shares — an estimated $206K sold.

BancorpSouth first reported a position in NVS in Q1 2014 and held it in 9 quarters. The position peaked at $460K in Q3 2014. 877 funds tracked by Wall St. Rank hold NVS as of Q3 2016.

BancorpSouth reported no remaining Novartis position as of Q3 2016 after selling out during the quarter.
BancorpSouth sold 2,783 Novartis shares in Q3 2016, an estimated $206K.
BancorpSouth first reported a position in Novartis in Q1 2014 and held it in 9 quarters.
BancorpSouth's Novartis position peaked at $460K in Q3 2014.
877 funds tracked by Wall St. Rank held Novartis as of Q3 2016.

Based on BancorpSouth's 13F filing for Q3 2016, filed 8 Nov 2016.